Nuwellis (NUWE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Executive summary
Supplement updates the number of outstanding shares and security ownership as of March 24, 2026.
Annual Meeting of Stockholders is scheduled for April 28, 2026.
Proxy card and voting procedures remain unchanged; prior votes remain valid.
Voting matters and shareholder proposals
Each share of common stock is entitled to one vote on each matter at the meeting.
Stockholders are encouraged to vote prior to the Annual Meeting using described methods.
Proxy cards already submitted remain valid; no further action needed if already voted.
Board of directors and corporate governance
Katharyn Field and Mika Grasso joined the Board on January 21, 2026, and resigned on March 26, 2026.
Carisa Schultz was appointed Chief Financial Officer effective February 2, 2026.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Nuwellis
- Best-efforts offering targets $4.4M for working capital, with high dilution and ongoing losses.NUWE
Registration filing4 Jun 2026 - Pediatric and critical care growth, innovation, and operational discipline drive revenue momentum.NUWE
Investor presentation2 Jun 2026 - Offering up to $4.4M in equity and warrants, with high dilution and operational risks.NUWE
Registration filing29 May 2026 - Up to $4.4M sought via equity and warrants to fund operations amid high product and financial risk.NUWE
Registration filing22 May 2026 - Revenue up 26% to $2.4M, gross margin 70.1%, net loss $4.5M, with new patents and capital needs.NUWE
Q1 202615 May 2026 - Board seeks approval for director elections and auditor ratification, emphasizing governance.NUWE
Proxy filing2 Apr 2026 - Q4 revenue and margin gains, strategic moves, and new leadership set up 2026 growth.NUWE
Q4 202520 Mar 2026 - Innovative fluid management platform targets $4.2B market with strong clinical and financial momentum.NUWE
Investor presentation10 Mar 2026 - Registering 4.28M shares for resale, proceeds from warrant exercises support working capital.NUWE
Registration Filing4 Feb 2026